Odyssey Health (ODYY) Long-Term Deferred Tax (2014 - 2025)

Odyssey Health's (ODYY) quarterly Long-Term Deferred Tax came in at $12.5 million in Q3 2025, up 2.23% year-on-year from $12.2 million in Q3 2024, and up 2.23% quarter-over-quarter from $12.2 million in Q3 2024.

Odyssey Health (ODYY) Long-Term Deferred Tax (2014 - 2025) Analysis & Trends

Odyssey Health's Long-Term Deferred Tax history runs 8 years deep, the most recent figure standing at $12.5 million for Q3 2025.

  • On a quarterly basis, Long-Term Deferred Tax rose 2.23% year-over-year to $12.5 million in Q3 2025; TTM through Jul 2025 was $12.5 million, a 2.23% increase from a year earlier, with the FY2025 full-year figure at $12.5 million, up 2.23% from the prior year.
  • Long-Term Deferred Tax improved to $12.5 million in Q3 2025 per ODYY's latest filing, from $12.2 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $12.5 million in Q3 2025 and bottomed at $12.2 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Odyssey Health 1.08 Mn 782,508.17 -

Historic Data

Download Data
DateValue
Jul 31, 2025 12.45 Mn
Jul 31, 2024 12.18 Mn
Apr 30, 2019 349,884.00
Jan 31, 2019 336,492.00
Oct 31, 2018 324,453.00
Apr 30, 2018 275,244.00
Jan 31, 2018 249,496.00
Oct 31, 2017 208,968.00
Jul 31, 2017 275,244.00
Apr 30, 2017 194,240.00
Jan 31, 2017 184,391.00
Oct 31, 2016 155,326.00
Jul 31, 2016 107,030.00
Apr 30, 2016 133,027.00
Jan 31, 2016 130,162.00
Oct 31, 2015 115,778.00
Jul 31, 2015 107,030.00
Jan 31, 2015 84,197.00
Oct 31, 2014 66,004.00
Jul 31, 2014 50,786.00